Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2026

Every FDA drug recall initiated in 2026, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

563 recalls, newest first.

Class II · Moderate risk

Icosapent Ethyl Capsules

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Ongoing Failed specification Zydus Pharmaceuticals (USA) Inc D-0400-2026
Class II · Moderate risk

Product label: Temozolomide Capsules

Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

Ongoing Impurity / degradation Rising Pharma Holding, Inc. NDC 16571-816-51 D-0384-2026

Recalls by year